Opinion & insight

A space for healthcare professionals to freely share and discuss their opinions and experiences. Please contact us if you’d like to contribute.

Latest insight from the epgonline team

Allen Wellings

UEGW 2018 | Day 5 Highlights

Posted 10 months ago

A number of presentations and abstracts shared updates on the latest developments for new treatments and therapies, some of which are pioneering new modes of action. Here we look to the horizon, gaining insights into the latest data for novel treatments targeting Janus kinase (JAK) signalling, MAdCAM-1-mediated adhesion and the interleukin IL-23.
 

 

Georgina Mason

UEGW 2018 | Day 4 Highlights

Posted 10 months ago

While clinical trials have demonstrated the efficacy of new biologics used in ulcerative colitis and/or Crohn’s disease, it is apparent that patients enrolled into clinical trials are not representative of the general patient population. Real-world evidence offers the chance to fill this gap and provide insights into how these treatments perform in everyday clinical practice. In today’s article we review some of the real-world data shared at UEG Week on vedolizumab and ustekinumab, as well as comparison of the originator and biosimilar versions of infliximab.

Georgina Mason

UEGW 2018 | Day 3 Highlights

Posted 10 months ago

The introduction of biologic therapies in the last 20 years has revolutionised the management of IBD. However, questions remain over the best approach to its management, such as when to introduce, switch and de-escalate biologics. Several posters and presentations addressed these topics at UEG Week 2018; here is a selection of some of the highlights.

Stephen Smith

UEGW 2018 | Day 2 Highlights

Posted 10 months ago

In this article, we provide an overview of some of the presentations and posters at UEG Week 2018 that studied the course of IBD and investigated the associated risk of cancer.

Stephen Smith

UEGW 2018 | Day 1 Highlights

Posted 10 months ago

A series of presentations and posters at UEG Week 2018 explored resource utilisation, the costs associated with IBD management and whether we can predict who may need additional resources...

The Asthma Report

ERS 2018 | Day 4 Highlights

Posted 1 year ago

A look at two sessions from the ERS Congress dealing with devices for the management of asthma and an in-depth look at some of the allergic responses to asthma.

 

Opinion archive